The present invention relates to compounds of formula I
wherein R, R4 and Q are each as defined herein. The compounds of the present invention are inhibitors of heat shock factor 1 pathway (HSF1 pathway). In particular, the present invention relates to the use of these compounds as therapeutic agents for the treatment and/or prevention of proliferative diseases, such as cancer. The present invention also relates to processes for the preparation of these compounds, and to pharmaceutical compositions comprising them.
本发明涉及式 I 的化合物
其中R、R4和Q各自如本文所定义。本发明的化合物是热休克因子 1 途径(HSF1 途径)的
抑制剂。特别是,本发明涉及将这些化合物用作治疗和/或预防增殖性疾病(如癌症)的治疗剂。本发明还涉及这些化合物的制备工艺以及包含这些化合物的药物组合物。